questionsmedicales.fr
Tumeurs
Tumeurs par type histologique
Tumeurs épithéliales épidermoïdes et glandulaires
Carcinomes
Adénocarcinome
Adénocarcinome papillaire
Carcinome papillaire folliculaire
Carcinome papillaire folliculaire : Questions médicales fréquentes
Diagnostic
5
Carcinome
Thyroïde
Biopsie
Échographie
Scintigraphie
Analyse sanguine
Nodule thyroïdien
Symptômes
Difficulté à avaler
Biopsie
Carcinome
Diagnostic
Analyse sanguine
Marqueurs tumoraux
Diagnostic
Symptômes
5
Symptômes
Nodule thyroïdien
Douleur au cou
Douleur
Nodule thyroïdien
Carcinome
Symptômes
Changement de voix
Difficulté à avaler
Symptômes
Diagnostic précoce
Carcinome
Symptômes
Nodule thyroïdien
Carcinome
Prévention
5
Prévention
Suivi médical
Carcinome
Dépistage
Thyroïde
Examen médical
Antécédents familiaux
Risque
Carcinome
Mode de vie
Prévention
Risque
Alimentation
Prévention
Carcinome
Traitements
5
Chirurgie
Hormonothérapie
Radiothérapie
Chirurgie
Carcinome
Traitement
Hormonothérapie
Thyroïde
Traitement
Radiothérapie
Carcinome
Traitement
Effets secondaires
Traitement
Carcinome
Complications
5
Complications
Récidive
Hormonothérapie
Propagation
Ganglions lymphatiques
Carcinome
Risques
Traitement
Hormonothérapie
Suivi médical
Complications
Traitement
Qualité de vie
Complications
Soutien médical
Facteurs de risque
5
Facteurs de risque
Carcinome
Antécédents familiaux
Radiation
Facteurs de risque
Carcinome
Régime alimentaire
Iode
Facteurs de risque
Stress
Santé
Facteurs de risque
Maladies thyroïdiennes
Facteurs de risque
Carcinome
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Carcinome papillaire folliculaire : Questions médicales les plus fréquentes",
"headline": "Carcinome papillaire folliculaire : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Carcinome papillaire folliculaire : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-02-25",
"dateModified": "2026-08-13",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Carcinome papillaire folliculaire"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Adénocarcinome papillaire",
"url": "https://questionsmedicales.fr/mesh/D000231",
"about": {
"@type": "MedicalCondition",
"name": "Adénocarcinome papillaire",
"code": {
"@type": "MedicalCode",
"code": "D000231",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C04.557.470.200.025.085"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Carcinome papillaire folliculaire",
"alternateName": "Carcinoma, Papillary, Follicular",
"code": {
"@type": "MedicalCode",
"code": "D018265",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Mitsuyoshi Hirokawa",
"url": "https://questionsmedicales.fr/author/Mitsuyoshi%20Hirokawa",
"affiliation": {
"@type": "Organization",
"name": "Departments of Diagnostic Pathology, Kuma Hospital, Kobe 650-0011, Japan."
}
},
{
"@type": "Person",
"name": "Akira Miyauchi",
"url": "https://questionsmedicales.fr/author/Akira%20Miyauchi",
"affiliation": {
"@type": "Organization",
"name": "Departments of Surgery, Kuma Hospital, Kobe 650-0011, Japan."
}
},
{
"@type": "Person",
"name": "Yasuhiro Ito",
"url": "https://questionsmedicales.fr/author/Yasuhiro%20Ito",
"affiliation": {
"@type": "Organization",
"name": "Departments of Surgery, Kuma Hospital, Kobe 650-0011, Japan."
}
},
{
"@type": "Person",
"name": "Deolino João Camilo-Júnior",
"url": "https://questionsmedicales.fr/author/Deolino%20Jo%C3%A3o%20Camilo-J%C3%BAnior",
"affiliation": {
"@type": "Organization",
"name": "Pathology Institute of Araçatuba, Araçatuba, Brazil."
}
},
{
"@type": "Person",
"name": "Miyoko Higuchi",
"url": "https://questionsmedicales.fr/author/Miyoko%20Higuchi",
"affiliation": {
"@type": "Organization",
"name": "Department of Laboratory Medicine, Kuma Hospital, Kobe 856-8562, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Concurrent identification of follicular lymphoma and papillary thyroid carcinoma.",
"datePublished": "2024-07-06",
"url": "https://questionsmedicales.fr/article/39137643",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ijscr.2024.110009"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comparison of Treatment and Prognosis Between Follicular Variant Papillary Thyroid Carcinoma and Classical Papillary Thyroid Carcinoma.",
"datePublished": "2023-10-09",
"url": "https://questionsmedicales.fr/article/37813352",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/a-2177-3413"
}
},
{
"@type": "ScholarlyArticle",
"name": "A patient with a rare co-occurrence of papillary and follicular thyroid carcinomas.",
"datePublished": "2024-04-05",
"url": "https://questionsmedicales.fr/article/38585590",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/ccr3.8707"
}
},
{
"@type": "ScholarlyArticle",
"name": "Digital analyses of nuclear features can help discriminate among non-invasive follicular thyroid neoplasm with papillary-like nuclear features, papillary thyroid carcinoma follicular subtype, and follicular carcinoma in cytological specimens.",
"datePublished": "2023-09-09",
"url": "https://questionsmedicales.fr/article/37688777",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/cyt.13305"
}
},
{
"@type": "ScholarlyArticle",
"name": "Comprehensive genomic profiling of infiltrative follicular variant of papillary thyroid carcinoma.",
"datePublished": "2024-08-14",
"url": "https://questionsmedicales.fr/article/39141684",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/cncr.35517"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Tumeurs",
"item": "https://questionsmedicales.fr/mesh/D009369"
},
{
"@type": "ListItem",
"position": 3,
"name": "Tumeurs par type histologique",
"item": "https://questionsmedicales.fr/mesh/D009370"
},
{
"@type": "ListItem",
"position": 4,
"name": "Tumeurs épithéliales épidermoïdes et glandulaires",
"item": "https://questionsmedicales.fr/mesh/D009375"
},
{
"@type": "ListItem",
"position": 5,
"name": "Carcinomes",
"item": "https://questionsmedicales.fr/mesh/D002277"
},
{
"@type": "ListItem",
"position": 6,
"name": "Adénocarcinome",
"item": "https://questionsmedicales.fr/mesh/D000230"
},
{
"@type": "ListItem",
"position": 7,
"name": "Adénocarcinome papillaire",
"item": "https://questionsmedicales.fr/mesh/D000231"
},
{
"@type": "ListItem",
"position": 8,
"name": "Carcinome papillaire folliculaire",
"item": "https://questionsmedicales.fr/mesh/D018265"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Carcinome papillaire folliculaire - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Carcinome papillaire folliculaire",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-08-26",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Carcinome papillaire folliculaire",
"description": "Comment diagnostiquer un carcinome papillaire folliculaire ?\nQuels tests sont utilisés pour le diagnostic ?\nQuels signes indiquent un carcinome papillaire ?\nQuelle est l'importance de la biopsie ?\nPeut-on détecter ce cancer par des analyses sanguines ?",
"url": "https://questionsmedicales.fr/mesh/D018265#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Carcinome papillaire folliculaire",
"description": "Quels sont les symptômes courants ?\nLe carcinome papillaire cause-t-il des douleurs ?\nY a-t-il des symptômes spécifiques à surveiller ?\nLes symptômes apparaissent-ils rapidement ?\nPeut-on avoir des symptômes sans nodule visible ?",
"url": "https://questionsmedicales.fr/mesh/D018265#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Carcinome papillaire folliculaire",
"description": "Peut-on prévenir le carcinome papillaire ?\nQuels examens de dépistage sont recommandés ?\nLes antécédents familiaux influencent-ils le risque ?\nLe mode de vie peut-il réduire le risque ?\nFaut-il éviter certains aliments ?",
"url": "https://questionsmedicales.fr/mesh/D018265#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Carcinome papillaire folliculaire",
"description": "Quels traitements sont disponibles ?\nLa chirurgie est-elle toujours nécessaire ?\nQu'est-ce que l'hormonothérapie ?\nLa radiothérapie est-elle utilisée ?\nQuels sont les effets secondaires des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D018265#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Carcinome papillaire folliculaire",
"description": "Quelles complications peuvent survenir ?\nLe carcinome papillaire peut-il se propager ?\nQuels sont les risques après traitement ?\nComment gérer les complications ?\nLes complications affectent-elles la qualité de vie ?",
"url": "https://questionsmedicales.fr/mesh/D018265#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Carcinome papillaire folliculaire",
"description": "Quels sont les principaux facteurs de risque ?\nL'exposition à la radiation est-elle un facteur ?\nLe régime alimentaire influence-t-il le risque ?\nLe stress a-t-il un impact sur le risque ?\nLes maladies thyroïdiennes augmentent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D018265#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un carcinome papillaire folliculaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic se fait par échographie, biopsie et analyses histologiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'échographie, la scintigraphie et les analyses sanguines."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un carcinome papillaire ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des nodules thyroïdiens, des changements de voix ou des difficultés à avaler peuvent indiquer."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de la biopsie ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La biopsie permet de confirmer la présence de cellules cancéreuses dans la thyroïde."
}
},
{
"@type": "Question",
"name": "Peut-on détecter ce cancer par des analyses sanguines ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs tumoraux peuvent être détectés, mais le diagnostic nécessite souvent une biopsie."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nodules, des douleurs au cou et des changements de voix."
}
},
{
"@type": "Question",
"name": "Le carcinome papillaire cause-t-il des douleurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il peut provoquer des douleurs au cou, surtout si le nodule est volumineux."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes spécifiques à surveiller ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveillez les changements de voix, la difficulté à avaler et les nodules visibles."
}
},
{
"@type": "Question",
"name": "Les symptômes apparaissent-ils rapidement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent se développer lentement, rendant le diagnostic précoce difficile."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans nodule visible ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes comme la douleur ou des changements de voix peuvent survenir sans nodule."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le carcinome papillaire ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais un suivi régulier est conseillé."
}
},
{
"@type": "Question",
"name": "Quels examens de dépistage sont recommandés ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des examens réguliers de la thyroïde peuvent aider à détecter des anomalies précocement."
}
},
{
"@type": "Question",
"name": "Les antécédents familiaux influencent-ils le risque ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de cancer de la thyroïde augmentent le risque."
}
},
{
"@type": "Question",
"name": "Le mode de vie peut-il réduire le risque ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, incluant une alimentation équilibrée, peut aider à réduire le risque."
}
},
{
"@type": "Question",
"name": "Faut-il éviter certains aliments ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'y a pas d'aliments spécifiques à éviter, mais une alimentation équilibrée est conseillée."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent la chirurgie, l'hormonothérapie et la radiothérapie."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle toujours nécessaire ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "La chirurgie est souvent nécessaire pour retirer le tissu tumoral et prévenir la propagation."
}
},
{
"@type": "Question",
"name": "Qu'est-ce que l'hormonothérapie ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hormonothérapie aide à réguler les niveaux d'hormones thyroïdiennes après la chirurgie."
}
},
{
"@type": "Question",
"name": "La radiothérapie est-elle utilisée ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la radiothérapie peut être utilisée pour traiter les cas avancés ou récurrents."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires peuvent inclure fatigue, douleurs et déséquilibres hormonaux."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent la récidive du cancer et des problèmes hormonaux post-chirurgicaux."
}
},
{
"@type": "Question",
"name": "Le carcinome papillaire peut-il se propager ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut se propager aux ganglions lymphatiques et à d'autres organes."
}
},
{
"@type": "Question",
"name": "Quels sont les risques après traitement ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent des déséquilibres hormonaux et des effets secondaires des traitements."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi médical régulier et un traitement approprié aident à gérer les complications."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les complications peuvent affecter la qualité de vie, nécessitant un soutien médical."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le sexe féminin, et des antécédents familiaux de cancer."
}
},
{
"@type": "Question",
"name": "L'exposition à la radiation est-elle un facteur ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des radiations, notamment lors de traitements médicaux, augmente le risque."
}
},
{
"@type": "Question",
"name": "Le régime alimentaire influence-t-il le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un régime pauvre en iode peut augmenter le risque de cancer de la thyroïde."
}
},
{
"@type": "Question",
"name": "Le stress a-t-il un impact sur le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress n'est pas directement lié au carcinome papillaire, mais peut affecter la santé globale."
}
},
{
"@type": "Question",
"name": "Les maladies thyroïdiennes augmentent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies thyroïdiennes, comme la thyroïdite, peuvent augmenter le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 13/08/2026
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Departments of Diagnostic Pathology, Kuma Hospital, Kobe 650-0011, Japan.
Publications dans "Carcinome papillaire folliculaire" :
4 publications dans cette catégorie
Affiliations :
Departments of Surgery, Kuma Hospital, Kobe 650-0011, Japan.
Publications dans "Carcinome papillaire folliculaire" :
2 publications dans cette catégorie
Affiliations :
Departments of Surgery, Kuma Hospital, Kobe 650-0011, Japan.
Publications dans "Carcinome papillaire folliculaire" :
2 publications dans cette catégorie
Affiliations :
Pathology Institute of Araçatuba, Araçatuba, Brazil.
Publications dans "Carcinome papillaire folliculaire" :
2 publications dans cette catégorie
Affiliations :
Department of Laboratory Medicine, Kuma Hospital, Kobe 856-8562, Japan.
Publications dans "Carcinome papillaire folliculaire" :
2 publications dans cette catégorie
Affiliations :
Department of Surgical, Medical, Molecular Pathology and Critical Area, University Hospital of Pisa, via Savi 10, 56126, Pisa, Italy. Electronic address: fulvio.basolo@med.unipi.it.
Publications dans "Carcinome papillaire folliculaire" :
2 publications dans cette catégorie
Affiliations :
Department of Pathology, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, India.
Publications dans "Carcinome papillaire folliculaire" :
2 publications dans cette catégorie
Affiliations :
Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
Publications dans "Carcinome papillaire folliculaire" :
2 publications dans cette catégorie
Affiliations :
Department of Diagnostic Pathology, Wakayama Medical University, 811-1 Kimiidera, Wakayama 641-8509, Japan.
Publications dans "Carcinome papillaire folliculaire" :
2 publications dans cette catégorie
Affiliations :
Cancer Molecular Pathology of School of Medicine and Dentistry, Menzies Health Institute Queensland, Griffith University, Gold Coast, QLD, Australia. a.lam@griffith.edu.au.
Pathology Queensland, Gold Coast University Hospital, Southport, QLD, Australia. a.lam@griffith.edu.au.
Faculty of Medicine, University of Queensland, Herston, QLD, Australia. a.lam@griffith.edu.au.
Publications dans "Carcinome papillaire folliculaire" :
1 publication dans cette catégorie
Affiliations :
College of Medicine, Princess Noura Bint Abdulrahman University, Riyadh, Saudi Arabia.
Publications dans "Carcinome papillaire folliculaire" :
1 publication dans cette catégorie
Affiliations :
College of Medicine, Princess Noura Bint Abdulrahman University, Riyadh, Saudi Arabia.
Publications dans "Carcinome papillaire folliculaire" :
1 publication dans cette catégorie
Affiliations :
General Surgery Department, Security Forces Hospital, Riyadh, Saudi Arabia.
Publications dans "Carcinome papillaire folliculaire" :
1 publication dans cette catégorie
Affiliations :
Otolaryngology-Head and Neck Surgery Department, King Fahad Medical City, Riyadh, Saudi Arabia.
Publications dans "Carcinome papillaire folliculaire" :
1 publication dans cette catégorie
Affiliations :
Breast and Endocrine Surgery Department, Security Forces Hospital, Riyadh, Saudi Arabia.
Publications dans "Carcinome papillaire folliculaire" :
1 publication dans cette catégorie
Affiliations :
Breast and Endocrine Surgery Department, Security Forces Hospital, Riyadh, Saudi Arabia. Electronic address: adil4470@gmail.com.
Publications dans "Carcinome papillaire folliculaire" :
1 publication dans cette catégorie
Affiliations :
Zhantansi Outpatient, Central Medical District of Chinese PLA General Hospital, Beijing, China.
Publications dans "Carcinome papillaire folliculaire" :
1 publication dans cette catégorie
Affiliations :
College of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital, Beijing, China.
Publications dans "Carcinome papillaire folliculaire" :
1 publication dans cette catégorie
Affiliations :
College of Otolaryngology Head and Neck Surgery, Chinese PLA General Hospital, Beijing, China.
Publications dans "Carcinome papillaire folliculaire" :
1 publication dans cette catégorie
Affiliations :
Zhantansi Outpatient, Central Medical District of Chinese PLA General Hospital, Beijing, China.
Publications dans "Carcinome papillaire folliculaire" :
PTC has high lymph node metastasis, affecting central and lateral lymph nodes. On the other hand, follicular lymphoma is the second most frequent non-Hodgkin lymphoma in the West and affects cervical ...
A 66-year-old Saudi man with type 2 diabetes and hypertension presented with neck lumps on both sides of his neck. The swelling was progressive, with no apparent cause, no history of hypothyroidism or...
Multiple malignant neoplasms are rare, but secondary primary cancers have been documented in patients with PTC. The occurrence of both cancers is commonly detected during follow-up and aided by modern...
A 66-year-old male was diagnosed with follicular lymphoma during a papillary thyroid carcinoma workup, emphasizing the importance of careful lymph node dissection and microscopic examination for rare ...
This cohort study evaluated the associations of different treatments with the prognosis of follicular variant papillary thyroid carcinoma (FVPTC) and classical papillary thyroid carcinoma (CPTC) patie...
The occurrence of papillary and follicular thyroid carcinoma as a collision tumor is rare. We report on a case of a collision tumor consisting of papillary and follicular thyroid carcinoma treated suc...
As it stands, the diagnosis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) is primarily based on histological analysis. We hypothesised that computerised anal...
We employed a retrospective analytical observational study based on nuclear morphometric variables of cytological material from thyroid nodules classified as PTCFS, NIFTP, or FC. Five cases of each en...
Regarding nuclear analysis, all variables differed among the three groups (p < 0.001). Given the interdependence among the variables, these data indicated that nuclear size was greatest in the NIFTP g...
Our analysis of the digital images, with a focus on nuclear parameters, found significantly difference among cytological specimens from cases of NIFTP, PTCFS and FC. Thus, this tool has the potential ...
Infiltrative follicular variant of papillary thyroid carcinoma (IFVPTC) exhibits nuclear characteristics typical of papillary thyroid carcinoma (PTC) but demonstrates a follicular growth pattern. The ...
Whole-exome sequencing of 50 IFVPTC tumor-normal pairs identified single-nucleotide variants, somatic copy number alterations (sCNAs), and subclonal architecture. Key mutations were verified via polym...
This study found that endogenous processes rather than exogenous mutagens dominated the shaping of the genome of IFVPTC during tumorigenesis. BRAF V600E was the only common trunk mutation and signific...
This study provides valuable insights into IFVPTC's genetic alterations and highlights the potential of HLA-C IHC to distinguish challenging-to-interpret IFVPTC and I-EFVPTC from NIFTP, which will enh...
Papillary thyroid carcinoma (PTC) stands out as the most prevalent epithelial malignant thyroid tumor. Thyroid primary follicular lymphoma (PFL) represents a rare malignant tumor originating from mese...
A 44-year-old female patient presented with a neck mass persisting for over 1 month. The patient underwent surgery, and the incised tissues were subjected to pathology examinations, along with immunoh...
The concurrent occurrence of PTC and PFL poses notable challenges in clinical practice, requiring careful consideration in diagnosis and treatment. Herein, we present a rare case of PTC combined with ...
Papillary and follicular thyroid carcinomas (PTC and FTC) are prominent malignancies that originate from thyroid follicular cells. PTC is usually diagnosed via preoperative cytology, and large tumor s...
Papillary thyroid carcinoma (PTC) and follicular thyroid carcinoma (FTC) contribute to more than 95% of thyroid malignancies. However, synchronous PTC and FTC are less common; it is most commonly disc...
We conducted a search of single PTC, single FTC, and synchronous PTC/FTC patients who received initial surgery treatment at Fudan University Shanghai Cancer Center from 2006 to 2018 and collected para...
Total of 42 synchronous PTC/FTC patients, 244 single FTC patients, and 2,959 single PTC patients were included. It showed a similarity between the clinicopathological features of synchronous thyroid c...
To conclude, synchronous PTC/FTC tend to be incidentally discovered during or after operation, behaving more like single PTC. The prognosis of synchronous patients is worse than that of single FTC pat...
Collision tumor comprise of existence of two histologically distinct and separate neoplasms in any organ. Thyroid gland is an uncommon site for these tumors, with frequently involved organs being live...
Columnar cell papillary thyroid carcinoma (CC-PTC) is a morphologic subtype of papillary thyroid carcinoma with a variable prognosis. It is characterized by neoplastic thyroid follicular-derived cells...
CC-PTC cases were identified from 3 institutions. Immunohistochemistry (ER, CDX2) and molecular testing (DNA and RNA sequencing) were performed. Clinicopathologic parameters and patient outcomes were ...
Twelve cases (2006-2023) were identified, all in adults (age 45-91). Two presented with disease outside the thyroid gland (neck and mediastinum) and two presented with distant metastasis. Four were hi...
This study represents the largest molecularly defined cohort of non-oncocytic thyroid carcinomas with columnar cell morphology. These tumors represent a genetically and behaviorally heterogeneous grou...